subject area of
- Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus Journal Articles
- Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy Journal Articles
- Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays Journal Articles
- Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Journal Articles
- Antiphospholipid antibodies and venous thromboembolism Journal Articles
- Free Protein S Deficiency May Be Found in Patients with Antiphospholipid Antibodies who Do not Have Systemic Lupus Erythematosus Journal Articles
- Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss Journal Articles
- Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss. Journal Articles
- Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children Conferences
- Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments] Journal Articles
- Lipoprotein(a): another risk factor for venous thrombosis? Journal Articles
- Lupus Anticoagulant Testing Journal Articles
- Neuropsychiatric Symptoms in Scleroderma Journal Articles
- Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism Journal Articles
- Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism Journal Articles
- The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group. Journal Articles